This page was added on 04 June 2021.
This page was updated on [date-counter-updated-date]. View history of updates
Registered for use in infants and children aged 2 months to 5 years.
Monovalent Haemophilus influenzae type b (Hib) vaccine
Lyophilised powder in a monodose vial with a pre-filled diluent syringe.
Each 0.5 mL reconstituted dose contains:
- 10 µg Hib capsular polysaccharide (polyribosyl-ribitol-phosphate) conjugated to 18–30 µg tetanus protein (PRP-T)
For Product Information and Consumer Medicine Information about Act-HIB visit the Therapeutic Goods Administration website.
Additional vaccine information
For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.